P. Taylor

发表

Cells Lacking the RB1 Tumor Suppressor Gene Are Hyperdependent on Aurora B Kinase for Survival.

D. Root, S. Signoretti, W. Kaelin, 2018, Cancer discovery.

Aurora kinase inhibitor nanoparticles target tumors with favorable therapeutic index in vivo

S. Barry, S. Ashton, P. Hall, 2016, Science Translational Medicine.

Anti-tumour and anti-vascular effects of cediranib (AZD2171) alone and in combination with other anti-tumour therapies

S. Wedge, J. Kendrew, A. Logié, 2013, Cancer Chemotherapy and Pharmacology.

Optimizing Therapeutic Effect of Aurora B Inhibition in Acute Myeloid Leukemia with AZD2811 Nanoparticles

S. Barry, S. Ashton, Shenghua Wen, 2017, Molecular Cancer Therapeutics.

Abstract A109: AZD9291: an irreversible, potent and selective third generation tyrosine kinase inhibitor (TKI) targeting EGFR activating (EGFRm+) and resistance (T790M) mutations in advanced lung adenocarcinoma.

W. Pao, S. Ashton, D. Cross, 2013 .

Modeling Dose and Schedule Effects of AZD2811 Nanoparticles Targeting Aurora B Kinase for Treatment of Diffuse Large B-cell Lymphoma

S. Barry, S. Ashton, Shenghua Wen, 2019, Molecular Cancer Therapeutics.

Modelling dose and schedule effects of AZD2811 nanoparticles targeting Aurora B kinase for treatment of diffuse large B-cell lymphoma

S. Barry, S. Ashton, J. Pilling, 2019 .

Optimizing Therapeutic Effect of Aurora B Inhibition in Acute Myeloid Leukemia with AZD2811 Nanoparticles

S. Barry, S. Ashton, Shenghua Wen, 2017, Molecular Cancer Therapeutics.